{'fraction_non_alphanumeric': 0.01600985221674877, 'fraction_numerical': 0.0, 'mean_word_length': 5.889830508474576, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Corporate Governance, Innovation, and Uncertainty: The Case of Start-up Companies in Biopharmaceuticals (Gouvernement d'entreprise, innovation et incertitude: Le cas des PME innovantes de la biopharmacie)

While numerous research works on Corporate Governance have been undertaken during the last fifteen years only very few attention has been devoted to the study of the way that contemporary economic and technological dynamics have affected governance issues, especially when innovation activities are involved. The aim of this paper is precisely to contribute to the necessary renewal of corporate governance analysis by attempting to highlight some crucial features and issues related to governance problems within industries witnessing radical and non reversible changes. The paper is organised as follows.